These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9152835)

  • 1. Psychological distress in applicants for predictive DNA testing for autosomal dominant, heritable, late onset disorders. The Rotterdam/Leiden Genetics Workgroup.
    DudokdeWit AC; Tibben A; Duivenvoorden HJ; Frets PG; Zoeteweij MW; Losekoot M; van Haeringen A; Niermeijer MF; Passchier J
    J Med Genet; 1997 May; 34(5):382-90. PubMed ID: 9152835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distress in individuals facing predictive DNA testing for autosomal dominant late-onset disorders: comparing questionnaire results with in-depth interviews. Rotterdam/Leiden Genetics Workgroup.
    DudokdeWit AC; Tibben A; Duivenvoorden HJ; Niermeijer MF; Passchier J; Trijsburg RW
    Am J Med Genet; 1998 Jan; 75(1):62-74. PubMed ID: 9450860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting adaptation to presymptomatic DNA testing for late onset disorders: who will experience distress? Rotterdam Leiden Genetics Workgroup.
    DudokdeWit AC; Tibben A; Duivenvoorden HJ; Niermeijer MF; Passchier J
    J Med Genet; 1998 Sep; 35(9):745-54. PubMed ID: 9733033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Course of distress experienced by persons at risk for an autosomal dominant inheritable disorder participating in a predictive testing program: an explorative study. Rotterdam/Leiden Genetics Workgroup.
    Dudok deWit AC; Duivenvoorden HJ; Passchier J; Niermeijer MF; Tibben A
    Psychosom Med; 1998; 60(5):543-9. PubMed ID: 9773756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychological functioning before predictive testing for Huntington's disease: the role of the parental disease, risk perception, and subjective proximity of the disease.
    Decruyenaere M; Evers-Kiebooms G; Boogaerts A; Cassiman JJ; Cloostermans T; Demyttenaere K; Dom R; Fryns JP
    J Med Genet; 1999 Dec; 36(12):897-905. PubMed ID: 10593997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks? Rotterdam/Leiden Genetics Working Group.
    Lodder LN; Frets PG; Trijsburg RW; Meijers-Heijboer EJ; Klijn JG; Duivenvoorden HJ; Tibben A; Wagner A; van der Meer CA; Devilee P; Cornelisse CJ; Niermeijer MF
    J Med Genet; 1999 Dec; 36(12):906-13. PubMed ID: 10593998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing.
    Lodder L; Frets PG; Trijsburg RW; Tibben A; Meijers-Heijboer EJ; Duivenvoorden HJ; Wagner A; van Der Meer CA; Devilee P; Cornelisse CJ; Niermeijer MF
    Eur J Hum Genet; 2001 Jul; 9(7):492-500. PubMed ID: 11464240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "You're one of us now": young people describe their experiences of predictive genetic testing for Huntington disease (HD) and familial adenomatous polyposis (FAP).
    Duncan RE; Gillam L; Savulescu J; Williamson R; Rogers JG; Delatycki MB
    Am J Med Genet C Semin Med Genet; 2008 Feb; 148C(1):47-55. PubMed ID: 18189288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experiences of predictive testing in young people at risk of Huntington's disease, familial cardiomyopathy or hereditary breast and ovarian cancer.
    MacLeod R; Beach A; Henriques S; Knopp J; Nelson K; Kerzin-Storrar L
    Eur J Hum Genet; 2014 Mar; 22(3):396-401. PubMed ID: 23860040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA diagnosis and the emergence of cancer genetic services in European health care.
    Stemerding D; Koch L; Bourret P
    Eur J Hum Genet; 1997; 5 Suppl 2():25-30. PubMed ID: 9450191
    [No Abstract]   [Full Text] [Related]  

  • 11. Psychological effects of presymptomatic DNA testing for Huntington's disease in the Dutch program.
    Tibben A; Duivenvoorden HJ; Niermeijer MF; Vegter-van der Vlis M; Roos RA; Verhage F
    Psychosom Med; 1994; 56(6):526-32. PubMed ID: 7871108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychological distress in the 5-year period after predictive testing for Huntington's disease.
    Decruyenaere M; Evers-Kiebooms G; Cloostermans T; Boogaerts A; Demyttenaere K; Dom R; Fryns JP
    Eur J Hum Genet; 2003 Jan; 11(1):30-8. PubMed ID: 12529703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychological consequences of predictive genetic testing: a systematic review.
    Broadstock M; Michie S; Marteau T
    Eur J Hum Genet; 2000 Oct; 8(10):731-8. PubMed ID: 11039571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of psychological functioning one year after the predictive test for Huntington's disease and impact of the test result on reproductive decision making.
    Decruyenaere M; Evers-Kiebooms G; Boogaerts A; Cassiman JJ; Cloostermans T; Demyttenaere K; Dom R; Fryns JP; Van den Berghe H
    J Med Genet; 1996 Sep; 33(9):737-43. PubMed ID: 8880572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do Attachment Style and Emotion Regulation Strategies Indicate Distress in Predictive Testing?
    van der Meer LB; van Duijn E; Giltay EJ; Tibben A
    J Genet Couns; 2015 Oct; 24(5):862-71. PubMed ID: 25641254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-year follow-up after presymptomatic testing for Huntington's disease in tested individuals and partners.
    Tibben A; Timman R; Bannink EC; Duivenvoorden HJ
    Health Psychol; 1997 Jan; 16(1):20-35. PubMed ID: 9028813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The challenge of using SNPs in the understanding and treatment of disease.
    Schifreen RS; Storts DR; Buller AM
    Biotechniques; 2002 Jun; Suppl():14-6, 18, 20-1. PubMed ID: 12083392
    [No Abstract]   [Full Text] [Related]  

  • 18. A theoretical psychological perspective on predictive testing for late onset hereditary diseases.
    Mularczyk E; Decruyenaere M; Denayer L; Evers-Kiebooms G
    Genet Couns; 2007; 18(4):367-78. PubMed ID: 18286817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paradox of a better test for Huntington's disease.
    Maat-Kievit A; Vegter-van der Vlis M; Zoeteweij M; Losekoot M; van Haeringen A; Roos R
    J Neurol Neurosurg Psychiatry; 2000 Nov; 69(5):579-83. PubMed ID: 11032607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presymptomatic testing for genetic diseases: new frontiers, new dilemmas.
    De Paepe A
    Acta Clin Belg; 2000; 55(5):244-8. PubMed ID: 11109638
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.